Your browser doesn't support javascript.
loading
Surgical Apgar score as a complication predictor in gastrointestinal oncologic surgery.
Padilla-Leal, K E; Flores-Guerrero, J E; Medina-Franco, H.
Afiliação
  • Padilla-Leal KE; Departamento de Cirugía, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico; Escuela de Medicina y Ciencias de la Salud del Tecnológico de Monterrey, Nuevo León, Mexico.
  • Flores-Guerrero JE; Departamento de Cirugía, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico; Universidad La Salle Victoria Campus de la Salud "Dr. Rodolfo Torre Cantú", Ciudad Victoria, Tamaulipas, Mexico.
  • Medina-Franco H; Departamento de Cirugía, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico. Electronic address: herimd@hotmail.com.
Rev Gastroenterol Mex (Engl Ed) ; 86(3): 259-264, 2021.
Article em En | MEDLINE | ID: mdl-34210460
INTRODUCTION AND AIMS: Surgical resection of gastrointestinal (GI) cancer is the cornerstone of curative treatment but entails considerable morbidity. The surgical Apgar score (SAS) is a practical and objective instrument that provides immediate feedback. The aim of the present study was to evaluate the performance of the SAS for predicting complications at 30 days in patients with primary GI cancer that underwent curative surgery. MATERIALS AND METHODS: A prospective observational study was conducted that included 50 patients classified into a low SAS (≤ 4) group or a high SAS (≥ 5) group. Complications were defined as any event classified as a Clavien-Dindo grade II to V event. Bivariate and multivariate analyses were performed through the Cox regression and a p<0.05 was considered significant. RESULTS: Overall postoperative morbidity was 50.0%, with no mortality. Eighty-six percent of cases were catalogued as having an ASA≥3. Eighty-eight percent had a high SAS, of whom 45.5% presented with a complication, whereas 12.0% had a low SAS and a complication rate of 83.3%. In the multivariate analysis, the BMI (OR: 3.351, 95% CI: 1.218-9.217, P=.019), SAS (OR: 0.266, 95% CI: 0.077-0.922, P=.037), surgery duration (OR: 3.170, 95% CI: 1.092-9.198, P=.034), and ephedrine use (OR: 0.356, 95% CI: 0.144-0.880, P=.025) were significantly associated with the development of adverse outcomes. CONCLUSIONS: SAS was shown to be an independent predictive factor of postoperative morbidity at 30 days in the surgical management of GI cancer and appears to offer a reliable sub-stratification in a high-risk population with an ASA≥3.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos do Sistema Digestório / Neoplasias Gastrointestinais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Newborn Idioma: En Revista: Rev Gastroenterol Mex (Engl Ed) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México País de publicação: México
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos do Sistema Digestório / Neoplasias Gastrointestinais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Newborn Idioma: En Revista: Rev Gastroenterol Mex (Engl Ed) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México País de publicação: México